studies on retatrutide Phase III study demonstrates 30% weight loss ✨ THE BUZZ AROUND RETATRUTIDE

Gastrointestinal issues such as nausea, constipation, diarrhoea, and reduced appetite are the most reported symptoms with weight loss injections

They describe the same skin-laxity phenomenon across body areas: when fat exits rapidly, the dermis above it regardless of anatomical location experiences mechanical stress that accelerates breakdown of existing collagen and elastin

Neither peptide has been studied in combination in formal clinical trials, so this stack falls into the territory of informed experimentation based on how each compound works independently

Yanai H, Adachi H, Hakoshima M, Katsuyama H (2024) Pathology and Treatments of Alzheimers Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes

Savage DC

This is why tirzepatide outperforms semaglutide in most clinical studies